Background-Healthcare reform initiatives in the United States have rekindled debate about the role of government regulation in the healthcare system. Although New York State (NYS) historically has had twice as many coronary revascularizations performed as Ontario, the relative evolution of coronary revascularization patterns in both jurisdictions over time is unknown. Methods and Results-We conducted an observational study comparing the temporal trends of cardiac invasive procedures use in NYS and Ontario using population-based data from 1997 to 2006 stratified by procedure indication. For nonacute myocardial infarction patients, the age-and sex-adjusted rate of percutaneous coronary intervention (PCI) was 2.3 times (95% confidence interval, 2.2 to 2.5) greater in NYS than in Ontario in 2004 to 2006. In contrast, population-based rates of coronary artery bypass grafting among nonacute myocardial infarction patients were not significantly different. For acute myocardial infarction patients, differences in coronary revascularization rates between NYS and Ontario narrowed substantially over time. In 2004 to 2006, the relative ratio was 1.3 times higher for PCI (95% confidence interval, 1.2 to 1.5) and 1.4 times higher (95% confidence interval, 1.1 to 1.8) for coronary artery bypass grafting in NYS relative to Ontario. However, a larger relative gap (relative ratio, 2.0; 95% confidence interval, 1.7 to 2.3) was observed among acute myocardial infarction patients undergoing emergency PCIs in NYS compared with Ontario. Conclusions-The market-oriented financing approach in NYS is associated with markedly higher rates of PCI procedures for both discretionary indications (eg, PCI in nonacute myocardial infarction patients) and emergent indications (eg, primary PCI) compared with the government-funded single-payer system in Ontario. (Circulation. 2010;121:2635-2644.)
I n the early 1990s, New York State (NYS) had twice as many percutaneous coronary intervention (PCI) procedures and coronary artery bypass graft (CABG) procedures performed as Ontario. 1 This difference in procedures rates was attributed in part to the different methods used to finance health care in the United States and Canada. 2, 3 The US market-oriented healthcare system, even with Certificate of Need provisions, does not place any formal restrictions on the volume of cardiac procedures performed and allows hospitals in the same geographical area to set up potentially duplicative cardiac services. 4 -6 Invasive cardiac procedures are attractive to US hospitals because they are highly profitable and generate considerable revenue for hospitals. 4, 6, 7 In contrast, the volume of cardiac procedures, locations of cardiac hospitals, and funding of cardiac services in Canada are determined by the provincial governments. 8 
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Critics of the Canadian system have historically pointed to patients dying while awaiting CABG as a key limitation of Canada's universal healthcare system. 9 -11 In response to waiting list concerns, the Ontario government created the Cardiac Care Network (CCN) of Ontario in 1991, an independent advisory body composed of clinicians and administrators to assist with the management and monitoring of cardiac surgery waiting lists. 9, 10 This monitoring role was subsequently expanded to include other cardiac procedures such as cardiac catheterization and PCI. In addition, the government has periodically requested the CCN to convene expert advisory panels to recommend "evidencebased target rates" for cardiac procedures to guide its funding policies. 12, 13 This focus on timely access to invasive procedures has led to a substantial increase in the population rates of PCI and CABG and a substantial reduction in waiting times in Ontario to a median wait time of 3 days for PCI and 12 days for CABG in 2003 to 2004. 14 The urgent push to reform health care in the US has rekindled the debate about government involvement in regulating the healthcare system. 15, 16 Examining these 2 contrasting methods of healthcare financing over the past decade provides an opportunity to document their impact on usage patterns of coronary revascularization in NYS and Ontario and may yield important insights into optimizing its use in both healthcare systems. 17 Accordingly, we compared the population rates and temporal trends in the use of cardiac invasive procedures in NYS and Ontario.
Methods

Study Population and System Context
We compared population-based cohorts of adult patients undergoing cardiac invasive procedures from 1997 to 2006 in the United States and Canada using data from NYS and Ontario, respectively. NYS is the third most populous state in the United States, consisting of 19.3 million people, and Ontario is the most populous province in Canada with 13 million people. The Ontario government reimburses all cardiovascular invasive procedures for its citizens without user fees or copayments.
NYS Registry
The Cardiac Surgery Reporting System and the Percutaneous Coronary Intervention Reporting System were used to determine use rates for cardiac invasive procedures in NYS. 18 These registries have been used to collect information on NYS residents undergoing PCI and CABG in nonfederal hospitals since 1991 and 1989, respectively. Data on patient demographics, coexisting conditions, and procedure characteristics such as the types of devices used, including bare metal stents and drug-eluting stents, are included. 18
Ontario Registry
The Canadian Institutes for Health Information discharge abstract database and the CCN database were used to identify PCI and CABG procedures in Ontario. The discharge abstract database includes demographics and clinical information for all patients who are hospitalized in acute care hospitals in Canada. The CCN database is a prospective clinical registry of all patients undergoing PCI and CABG in Ontario. 19 Nurse coordinators at each cardiac invasive center gather data on patient demographics, clinical characteristics, comorbid conditions, and procedure characteristics. 19 
Statistical Analysis
We first compared the availability of resources that included populationbased rates of physicians (interventional cardiologists, cardiac surgeons) and hospitals with cardiac invasive facilities in NYS and Ontario. Crude rates of cardiac catheterization for adult patients Ͼ20 years of age were also calculated. We then calculated population-based use rates for PCI and CABG in NYS and Ontario for adult patients for each calendar year and stratified them according to procedure indication. The term coronary revascularization for recent acute myocardial infarction (AMI) was used when cardiac procedures were performed within 20 days of the AMI. The term coronary revascularization for non-AMI was used to denote cardiac procedures performed among patients without AMI or when cardiac procedures were performed Ͼ20 days after a recent AMI. The term emergency coronary revascularization was used when cardiac procedures were performed on the same day as the AMI. Age-and sex-specific rates for NYS and Ontario were calculated with the population of NYS in 2000 as our standard population. This method of direct standardization allowed estimation of procedure rates that would be expected in Ontario if it were to have the same population age and sex distributions as NYS. Direct standardization for age was performed with 5-years intervals. The average annual change in standardized procedure rates was calculated with Poisson regression with the population rate as the dependent variable and the calendar year of the procedure as the independent variable. This is possible because rate, expressed as the number of events in a specific time period, follows a Poisson distribution. 20 The absolute difference and relative ratio in population rates between NYS and Ontario were estimated in different time periods (1997 to 2000, 2001 to 2003, and 2004 to 2006) . A 2-sided value of PՅ0.05 was considered statistically significant. SAS version 9.1 (SAS Institute, Inc, Cary, NC) was used for statistical analyses.
Results
Interventional Cardiologists, Cardiac Surgeons, and Hospitals With Invasive Cardiac Facilities in NYS and Ontario
NYS had more interventional cardiologists, cardiac surgeons, and cardiac hospitals with invasive facilities per capita compared with Ontario throughout the study period (Table 1 ). In 2004 to 2006, the relative ratio was 2.9 for interventional cardiologists, 1.8 for cardiac surgeons, 2.6 for hospitals with PCI facilities, and 2.2 for hospitals with CABG facilities. The relative ratio for physicians and hospitals with invasive facilities remained relatively stable over the entire study period.
Temporal Trends in Overall Use of Coronary Revascularization, PCI, and CABG in NYS and Ontario
In 2004 to 2006, the crude population-based rate of cardiac catheterization in NYS was 2 times higher than in Ontario. For coronary revascularization, the age-and sex-adjusted rate was 425.3 per 100 000 adults in NYS versus 255.1 per 100 000 in Ontario. The relative ratio in adjusted rates was 1.7 times, and the absolute difference in rates of coronary revascularization (170.2 per 100 000) was due entirely to the higher use of PCI procedures in NYS ( Table 2) .
NYS had more CABG surgery per capita compared with Ontario in 1997 to 2000. However, a greater decline in CABG rates in NYS over the study period (annual decline of 7.8% in NYS versus 2.6% in Ontario; PϽ0.001) led to almost identical population-based CABG rates between NYS and Ontario in 2004 to 2006 ( Table 2 ).
Temporal Trends in Coronary Revascularization, PCI, and CABG Among Patients Without AMI
In 2004 to 2006, NYS had 1.8 times as many coronary revascularizations per capita for patients without AMI after †PϽ0.001 for all annual average change in procedure rates during the study period except for trends in Ontario CABG rates, where Pϭ0.03. Negative value indicates declining procedure rate; positive value, increasing procedure rate during the study period.
age and sex adjustment compared with Ontario, with an absolute difference of 146.6 procedures per 100 000 adults ( Table 3 and Figure 1 ). This discrepancy was due to the difference in PCI procedures (absolute difference, 152.4 per 100 000), which increased further over the study period. Population rates of CABG did not differ significantly between NYS and Ontario in 2004 to 2006.
Temporal Trends in Coronary Revascularization, PCI, and CABG Among Patients With AMI
Although NYS had almost 3 times more coronary revascularizations per capita among patients with recent AMI in 1997, the gap narrowed substantially over time because of a greater increase in PCI in Ontario ( Figure 3 ). NYS also had 9 times (95% CI, 2.1 to 38.8) more emergency CABGs compared with Ontario, but the population rates were low in both jurisdictions. We performed a sensitivity analysis altering the definition of emergency coronary revascularization to include procedures that were performed the next day after an AMI admission. We found that NYS had 1.8 times (95% CI, 1.6 to 2.1) as many emergency PCIs and 4.0 times (95% CI, 1.7 to 9.2) as many emergency CABGs per capita as in Ontario during the 2004 to 2006 time period.
Discussion
We examined the evolution of the use of cardiac invasive procedures in NYS and Ontario over time to gain insights into the impact of different financing of healthcare approaches. For patients without AMI, NYS had more than twice as many PCI procedures as Ontario per capita after age and sex adjustment throughout the entire study period. In contrast, population-based rates of CABG among non-AMI patients were no longer significantly different at the end of the study period. For patients with recent AMI, the gap in both types of coronary revascularization between NYS and Ontario narrowed significantly over time. However, the population rate for emergency PCI procedures in Ontario was still half of that in NYS in the contemporary period of 2004 to 2006.
If one assumes that the underlying burden of cardiac disease is similar between the 2 jurisdictions, our findings suggest that a market-oriented financing approach (with no capacity constraints) leads to much greater use of PCI procedures for more discretionary indications (eg, in patients without AMI) but also provides better access to emergency cardiac invasive procedures. Our findings underscore a challenge associated with evaluating government deregulation: A market-oriented approach may lead to more use of both discretionary and nondiscretionary cardiac procedures. Furthermore, similar rates of CABG suggest that regional practice patterns also may have an important influence on revascularization patterns in addition to the impact of the financing structures of healthcare systems.
A market-oriented approach to financing cardiac procedures provides incentives for providers to maximize the volume of procedures performed and incentives for hospitals to set up Abbreviations as in Table 2 . *Patients without an AMI within 20 days of the coronary revascularization were included in this cohort. †PϽ0.001 for all estimates.
cardiac invasive facilities because cardiac procedures are profitable for hospitals. 4 -6 It is therefore not surprising that NYS has had a consistently greater supply of interventional cardiologists, cardiac surgeons, and hospitals with cardiac invasive facilities compared with Ontario, where the number of training positions for cardiac specialists is regulated through provincial funding policies. It has been shown that the use of cardiac invasive procedures is highly dependent on the availability of resources, 21 thus explaining why substantially greater numbers of additional cardiac catheterizations and subsequent PCI procedures are being performed among patients without AMI in NYS. 22 Given the lack of benefit of PCI in reducing death or myocardial infarction for patients with stable coronary artery disease compared with medical therapy as demonstrated in older clinical trials, 23 as well as more recent trials such as Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) 24 and Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D), 25 one might also question whether patients in NYS with stable coronary artery disease were undergoing more unnecessary PCI procedures compared with Ontario. 22 In Ontario, a government-regulated single-payer system controls the overall volume of cardiac procedures performed. Hospitals do not have additional financial incentives to set up additional facilities because duplication of services is minimized through regionalization. Financing for population-based rates of cardiac invasive procedures is determined by the government after consultation with expert panels of clinicians every few years. These expert panels recommend evidence-based target rates of cardiac procedures that reflect the perceived needs of the population. 12, 13 For example, the CCN convened an expert panel in late 2002 to revise population targets for cardiac procedures in Ontario. 13 On the basis of strong evidence demonstrating the benefits of an early invasive strategy in acute coronary syndrome, the government adopted new recommended targets to increase population-based rates of PCI substantially from 149 per 100 000 adults in 2002 to 260 per 100 000 adults in 2008. 13 Injection of government funding resulted in a more dramatic shift in referral patterns in patients with recent AMI in Ontario observed in our study compared with NYS despite a relatively constant difference in infrastructure and human resource. Accordingly, only a small difference in coronary revascularization rates among patients with recent AMI between the 2 jurisdictions remained in 2004 to 2006.
In contrast, a potential limitation of a single-payer system is that certain recommendations might not be approved for incremental funding by the government. In the case of emergency PCI, a CCN expert panel recommended a province-wide regionalized approach to increase access to primary PCI for patients with ST-segment elevation myocardial infarction on the basis that primary PCI improves patient outcomes compared with fibrinolytic therapy. 26 However, this approach was independently reviewed by the Ontario Health Technology Advisory Committee, which concluded that a regionalized system was not cost-effective and that a province-wide reorganization of emergency medical services was considered impractical by this arms-length expert committee. 27 As a consequence, no additional funding was devoted to a systematic approach of primary PCI. Accordingly, it is well documented that Ontario has had relatively limited access to primary PCI, with Ͻ10% of patients with STsegment elevation myocardial infarction treated with primary PCI in 1999 to 2001. 28 Even among PCI facilities, we found that only 33% of the 12 hospitals with PCI facilities were performing primary PCI around the clock in 2007. 29 Although we previously reported in 1997 that NYS had twice as many CABGs per capita as Ontario, 1 a sharper decline in the use of CABG was observed in NYS than in Ontario over the past decade. In 2004 to 2006, per capita rates of CABG were almost identical between the 2 jurisdictions. To put this into perspective, 5 PCI procedures were performed for each CABG in NYS compared with only 2 PCIs per CABG in Ontario. This is especially remarkable because CABG surgeries are profitable to American hospitals and NYS has twice as many cardiac surgeons and hospitals with cardiac surgery capability compared with Ontario. Our observation may relate to a greater preference for PCI by interventional cardiologists in NYS among patients suitable for CABG compared with Ontario, where patients were more likely to be referred for PCI and less likely to be referred for CABG than recommended by practice guidelines. 30 It has also been shown that the introduction of drug-eluting stents was associated with greater use of PCI in patients with multiple-vessel coronary artery disease. 31 Accordingly, a greater use of drug-eluting stents in NYS compared with Ontario might have accounted in part for the preference for PCI procedures. In both countries, interventional cardiologists rather than cardiac surgeons are the key decision makers as to whether patients are referred for PCI or CABG procedures. 30 Our observation suggests that local regional practice patterns, in addition to the financial structures, rules, and regulations in each country, may play a substantial role in influencing treatment patterns. Several limitations of our study merit consideration. First, we were not able to compare the appropriateness of cardiac procedure in NYS and Ontario because of the lack of necessary data elements. Older data comparing the appropri-ateness of revascularization between the United States and Canada have found the relative proportion of appropriate and inappropriate patients who underwent cardiac revascularization procedures to be similar. 32, 33 These observations were likely explained by the fact that physicians do not discriminate procedure use on the basis of appropriateness, and higher-use regions perform more indicated, unindicated, and discretionary procedures than lower-use regions, as shown by this study and others. 34 However, appropriateness criteria for coronary revascularization have changed substantially in the interim, so more contemporary evaluations are needed. Second, our definition of emergency coronary revascularization was based on the timing of the procedure because detailed information on emergency indication was not available in Ontario. However, the majority of PCIs in NYS according to this definition were emergency procedures because 80% of patients had ST-segment elevation myocardial infarction and 45% had ongoing cardiac ischemia. We evaluated the impact of funding policy on access to coronary invasive procedures but could not evaluate the potential impact of limited access on patient outcomes. It is reasonable to hypothesize that some patients in Ontario could have benefited from greater access to emergency cardiac procedures. However, comparing the outcomes of similar cohorts of high risk cardiac patients would be necessary to make more definitive conclusions.
Third, we could not compare the underlying burden of cardiac disease between NYS and Ontario. Yet, we do not believe potential differences in disease burden between the United States and Canada explained our findings. For example, the ageadjusted mortality rate for coronary heart disease was 278.8 per 100 000 in 2005 in the United States and 252.5 per 100 000 in 2004 in Canada. 35, 36 Furthermore, previous studies comparing patients hospitalized with an AMI in the United States and Canada have found similar baseline characteristics among hospitalized patients. 2, 3 We also did not have information on malpractice lawsuits for cardiovascular diseases in NYS and Ontario. It is possible that a greater concern for malpractice lawsuits in NYS compared with Ontario could have accounted for some additional coronary revascularizations.
Finally, we compared practice patterns in Ontario and NYS because comparable national data sets were not available. It has previously been demonstrated that population use rates of cardiac procedures in Ontario are highly representative of the overall rates in Canada. 37 In contrast, the practice of invasive cardiology in NYS may be more restrictive than other states because of public reporting and the Certificate of Need. 38, 39 However, this limitation would tend to minimize our ability to find a difference between NYS and Ontario.
Conclusions
Our study provides a new perspective on the influence of financing structure on the use of cardiac invasive procedures over time. A market-oriented approach with excess supply appears to be associated with greater use of PCI procedures for more discretionary indications such as in patients with stable coronary artery disease who may not actually require or benefit from the procedure. However, a government-funded approach may also restrict access to cardiac invasive procedures in emergency situations, and some patients in such systems may have benefited substantially from greater access to emergency PCI but did not receive it. Our study highlights the challenges involved in terms of potential policy options for trying to control the rising costs of health care while trying to optimize patient outcomes in both countries.
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